DexCom, Inc.
DXCM
$84.67
-$0.67-0.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.52% | 12.70% | -6.20% | -1.98% | -42.88% |
| Total Depreciation and Amortization | -19.46% | 34.72% | 6.14% | -0.76% | -23.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.84% | 1,209.68% | -138.27% | 286.21% | -113.10% |
| Change in Net Operating Assets | -93.75% | -59.49% | -76.63% | 255.79% | 107.36% |
| Cash from Operations | -39.02% | 51.08% | -28.60% | 33.56% | 56.59% |
| Capital Expenditure | 30.18% | -12.05% | -68.23% | -16.17% | -8.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 204.52% | -155.71% | 361.81% | -193.24% | -71.82% |
| Cash from Investing | 132.99% | -244.41% | 211.33% | -352.54% | -81.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.25% | -23.08% | 7.14% | 83.91% | -277.55% |
| Cash from Financing | 881.25% | 99.78% | -52,507.14% | -129.79% | 100.74% |
| Foreign Exchange rate Adjustments | 120.54% | -230.23% | 960.00% | 73.68% | -162.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,078.81% | 95.25% | -461.07% | -69.08% | 468.56% |